Select Bibliography

Filter by any of these (after searching):

IBCSG-24-02 (SOFT-TEXT)

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 15 items

Adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression: patient-reported outcomes in the TEXT and SOFT randomised trials

Bernhard, Jürg , Luo, Weixiu , Ribi, Karin , Colleoni, Marco ... - - Lancet Oncol. - 2015

Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Randomized comparison of adjuvant tamoxifen (T) plus ovarian function suppression (OFS) versus tamoxifen in premenopausal women with hormone receptor-positive (HR+) early breast cancer (BC): Update of the SOFT trial

Fleming, Gini F , Francis, Prudence A , Láng, István ... - SABCS - Ann. Oncol. - 2017

Abstract - Primary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

Francis, P. A. , Pagani, O. , Fleming, G. F. , Walley, B. A. ... - - N. Engl. J. Med. - 2018

Manuscript - Primary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT) , IBCSG-25-02 (TEXT) , S0002

Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

Francis, Prudence A. , Regan, Meredith M. , Fleming, Gini F. ... - - N. Engl. J. Med. - 2015

Manuscript - Primary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Long-Term Follow-Up of TEXT and SOFT Trials of Adjuvant Endocrine Therapies for Premenopausal Women with HR+ Early Breast Cancer

Francis, Prue , Fleming, Gini , Regan, Meredith , Pagani, Olivia ... - SABCS - Cancer Res - 2017

Abstract - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Randomized comparison of adjuvant aromatase inhibitor exemestane (E) plus ovarian function suppression (OFS) vs tamoxifen (T) plus OFS in premenopausal women with hormone receptor positive (HR+) early breast cancer (BC): Update of the combined TEXT and SOFT trials

Pagani, Olivia , Regan, Meredith M. , Fleming, Gini F. ... - SABCS - Cancer Res - 2018

Abstract - Primary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT) , IBCSG-25-02 (TEXT)

Adjuvant ovarian function suppression and cognitive function in women with breast cancer

Phillips, Kelly-Anne , Regan, Meredith M , Ribi, Karin ... - - Br. J. Cancer - 2016

Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Concurrent and sequential initiation of ovarian function suppression with chemotherapy in premenopausal women with endocrine-responsive early breast cancer: an exploratory analysis of TEXT and SOFT

Regan, M. M. , Walley, B. A. , Francis, P. A. , Fleming, G. F. ... - - Ann. Oncol - 2017

Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials

Regan, Meredith M. , Francis, Prudence A. , Pagani, Olivia ... - - J. Clin. Oncol - 2016

Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Adjuvant treatment of premenopausal women with endocrine-responsive early breast cancer: Design of the TEXT and SOFT trials

Regan, Meredith M. , Pagani, Olivia , Fleming, Gini F. ... - - Breast - 2013

Manuscript - No-Endpoint - Trial-Description-Only - Breast - IBCSG-24-02 (SOFT-TEXT)

Predictive value and clinical utility of centrally-assessed ER, PgR and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials

Regan, Meredith M. , Pagani, Olivia , Francis, Prudence A. ... - - Breast Cancer Res. Treat. - 2015

Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Adjuvant Tamoxifen Plus Ovarian Function Suppression Versus Tamoxifen Alone in Premenopausal Women With Early Breast Cancer: Patient-Reported Outcomes in the Suppression of Ovarian Function Trial

Ribi, Karin , Luo, Weixiu , Bernhard, Jürg , Francis, Prudence A. ... - - J. Clin. Oncol - 2016

Manuscript - Primary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

The effects of treatment-induced symptoms, depression and age on sexuality in premenopausal women with early breast cancer receiving adjuvant endocrine therapy

Ribi, Karin , Luo, Weixiu , Burstein, Harold J. ... - SABCS - Cancer Research - 2017

Abstract - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.

Ribi, Karin , Luo, Weixiu , Walley, Barbara A , Burstein, Harold J ... - - Breast Cancer Res Treat - 2020

Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)

Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

Saha, Poornima , Regan, Meredith M. , Pagani, Olivia ... - - J. Clin. Oncol - 2017

Manuscript - Secondary - Primary - Breast - IBCSG-24-02 (SOFT-TEXT)